Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Merck
Chubb
Deloitte
Covington
Cipla
Citi
Healthtrust
Accenture

Generated: April 25, 2018

DrugPatentWatch Database Preview

CLINDAMYCIN PALMITATE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Clindamycin Palmitate Hydrochloride patents expire, and what generic alternatives are available?

Clindamycin Palmitate Hydrochloride is a drug marketed by Amneal Pharms, Aurobindo Pharma Ltd, Lyne, Mylan Pharms Inc, Orit Labs Llc, and Paddock Llc. and is included in six NDAs.

The generic ingredient in CLINDAMYCIN PALMITATE HYDROCHLORIDE is clindamycin palmitate hydrochloride. There are fifty-five drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the clindamycin palmitate hydrochloride profile page.
Drug patent expirations by year for CLINDAMYCIN PALMITATE HYDROCHLORIDE
Pharmacology for CLINDAMYCIN PALMITATE HYDROCHLORIDE
Synonyms for CLINDAMYCIN PALMITATE HYDROCHLORIDE
[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] hexadecanoate;hydrochloride
[(2R,4S,5R)-6-[2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] hexadecanoate hydrochloride
[6-[2-chloro-1-[(1-methyl-4-propyl-pyrrolidine-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] hexadecanoate hydrochloride
25507-04-4
34850-73-2
35208-55-0 (Parent)
6-{2-chloro-1-[(1-methyl-4-propylpyrrolidin-2-yl)formamido]propyl}-4,5-dihydroxy-2-(methylsulfanyl)oxan-3-yl hexadecanoate hydrochloride
AB2000687
AB51459
AC-8823
AC1L1OVK
AKOS015963324
AKOS030242182
AN-7626
C-23416
C34H63ClN2O6S.HCl
C34H64Cl2N2O6S
CAS-25507-04-4
CHEBI:34647
CHEMBL1200632
Cleocin Pediatric
Cleocin pediatric (TN)
CLINDALYCIN PALMITATE HYDROCHLORIDE
Clindamycin 2-palmitate hydrochloride
Clindamycin palmitate HCl
Clindamycin palmitate hydrochloride (JAN/USP)
Clindamycin Palmitate Hydrochloride [USAN:JAN]
Clindamycin palmitate hydrochloride [USAN:USP:JAN]
Clindamycinpalmitatehydrochloride
CTK8F8720
D01990
DSSTox_CID_28660
DSSTox_GSID_48734
DSSTox_RID_82930
DTXSID3048734
J-016026
L-threo-alpha-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-2-hexadecanoate, monohydrochloride, (2S-trans)-
L-THREO-ALPHA-D-GALACTO-OCTOPYRANOSIDE, METHYL 7-CHLORO-6,7,8-TRIDEOXY-6-[[(1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL]AMINO]-1-THIO-,2-HEXADECANOATE, MONOHYDROCHLORIDE, (2S-TRANS)-
LS-174102
METHYL 7-CHLORO-6,7,8-TRIDEOXY-6-(1-METHYL-TRANS-4-PROPYL-L-2-PYRROLIDINECARBOXAMIDO)-1-THIO-L-THREO-ALPHA-D-GALACTO-OCTOPYRANOSIDE 2-HEXADECANOATE MONOHYDROCHLORIDE
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside 2-palmitate monohydrochloride
MolPort-003-983-293
MolPort-028-599-793
NCGC00185773-02
NSC-759141
NSC759141
O721
Pharmakon1600-01505470
s2596
SCHEMBL41416
Tox21_113175
U 25179E
U-25,179 E
UNII-VN9A8JM7M7
VN9A8JM7M7

US Patents and Regulatory Information for CLINDAMYCIN PALMITATE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms CLINDAMYCIN PALMITATE HYDROCHLORIDE clindamycin palmitate hydrochloride FOR SOLUTION;ORAL 203513-001 Mar 13, 2014 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Pharms Inc CLINDAMYCIN PALMITATE HYDROCHLORIDE clindamycin palmitate hydrochloride FOR SOLUTION;ORAL 203063-001 May 25, 2016 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma Ltd CLINDAMYCIN PALMITATE HYDROCHLORIDE clindamycin palmitate hydrochloride FOR SOLUTION;ORAL 202409-001 Apr 30, 2013 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lyne CLINDAMYCIN PALMITATE HYDROCHLORIDE clindamycin palmitate hydrochloride FOR SOLUTION;ORAL 201821-001 Aug 28, 2012 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Citi
Merck
Fuji
Johnson and Johnson
AstraZeneca
Medtronic
Boehringer Ingelheim
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.